← SynDRA
DABUZALGRON
SynDRA canonical compound SYN0008895 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | ADRB3 |
|---|
| Mechanism of action | adrenergic receptor agonist |
|---|
| Indication | urinary incontinence |
|---|
| Disease area | urology |
|---|
All known targets
Mechanisms of action (all sources)
- ADRA1A PARTIAL AGONIST
- Alpha-1a adrenergic receptor partial agonist
- ADRA1A AGONIST
- adrenergic receptor agonist
- ADRA1D AGONIST
Cross-references
Synonyms
- RO-115-1240
- R-450
- Alpha-1 adrenoceptor agonist, Roche
- Ro-115-1240
- dabuzalgronum
- LGX4GZ74WO
- CHEBI:142452
- RefChem:130707
- DTXCID1098836
- Ro115-1240
- Dabuzalgron [INN]
- UNII-LGX4GZ74WO
- Dabuzalgron?
- MFCD13195546
- GTPL3469
- orb1309790
- SCHEMBL5203336
- HMS3752I15
- EX-A4502
- BDBM50377398
- AKOS024257909
- AS-74067
- DA-62633
- HY-117071
- CS-0063649
- NS00121374
- A11062
- T10952
- F813170
- R 450
- Ro-1151240190
- Dabuzalgron hydrochloride (USAN)
- Dabuzalgron HCl
- RO115-1240/190
- Dabuzalgron hydrochloride
- RO-1151240
- CS-0077360
- UNII-A7Q00A39MF
Look up DABUZALGRON in the interactive SynDRA portal →